Safety and Tolerability Study of ISIS EIF4E Rx in Combination With Docetaxel and Prednisone (CRPC)

The recruitment status of this study is unknown because the information has not been verified recently.
Verified November 2012 by Isis Pharmaceuticals.
Recruitment status was  Active, not recruiting
Information provided by (Responsible Party):
Isis Pharmaceuticals Identifier:
First received: November 2, 2010
Last updated: November 1, 2012
Last verified: November 2012
No Study Results Posted on for this Study
  Study Status: This study is ongoing, but not recruiting participants.
  Estimated Study Completion Date: March 2015
  Estimated Primary Completion Date: September 2013 (Final data collection date for primary outcome measure)